Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-09

FDA Approved: LEVONEST — Supplemental Application (Northstar Rx LLC)

View source ↗

Summary

FDA approves a supplemental application for LEVONEST (levonorgestrel and ethinyl estradiol) from Northstar Rx LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVONEST (LEVONORGESTREL AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for LEVONEST (LEVONORGESTREL AND ETHINYL ESTRADIOL)